Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.88 BRL
70.40 M BRL
8.66 B BRL
40.46 M
About PROFARMA ON NM
Sector
Industry
CEO
Sammy Birmarcker
Website
Headquarters
Rio de Janeiro
Founded
1961
ISIN
BRPFRMACNOR1
FIGI
BBG000Q7N9J0
Profarma Distribuidora de Produtos Farmaceuticos SA provides wholesale operations to pharmaceutical retailers, with the sale of medicines and health and beauty products. It operates through the following segments: Pharmaceutical Distribution, Hospital and Specialties, and Retail. The Pharmaceutical Distribution segment is the core business and comprises wholesale operations to pharmaceutical retail, with the sale of medicines and personal care and beauty products. The Hospital and Specialties segment in hospital and dermatological products and vaccines. The Retail segment deals with pharmaceutical retail through the chains Drogasmil and Tamoio. The company was founded by Manoel Birmarcker in May 1961 and is headquartered in Rio de Janeiro, Brazil.
Análise Profarma 29/09/17Analisando o gráfico podemos identificar uma LTA se formando e indo buscar tapar o buraco tapar o GAP deixado no dia 17/05/17 onde encontrará pontos de força em aproximadamente 9 e 10 reais, onde ela já trabalhou algumas vezes no passado, que se superados terá pontos de forças mais fracos aproximada
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PFRM3 is 7.47 BRL — it hasn't changed in the past 24 hours. Watch PROFARMA ON NM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMFBOVESPA exchange PROFARMA ON NM stocks are traded under the ticker PFRM3.
PFRM3 stock has risen by 6.87% compared to the previous week, the month change is a 34.59% rise, over the last year PROFARMA ON NM has showed a 79.14% increase.
PFRM3 reached its all-time high on Feb 2, 2007 with the price of 28.47 BRL, and its all-time low was 2.49 BRL and was reached on Mar 23, 2020. View more price dynamics on PFRM3 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PFRM3 stock is 4.28% volatile and has beta coefficient of 1.62. Track PROFARMA ON NM stock price on the chart and check out the list of the most volatile stocks — is PROFARMA ON NM there?
Today PROFARMA ON NM has the market capitalization of 915.90 M, it has increased by 4.72% over the last week.
Yes, you can track PROFARMA ON NM financials in yearly and quarterly reports right on TradingView.
PROFARMA ON NM is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
PFRM3 net income for the last quarter is 49.02 M BRL, while the quarter before that showed 28.30 M BRL of net income which accounts for 73.20% change. Track more PROFARMA ON NM financial stats to get the full picture.
PROFARMA ON NM dividend yield was 5.38% in 2023, and payout ratio reached 57.11%. The year before the numbers were 4.01% and 22.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROFARMA ON NM EBITDA is 439.73 M BRL, and current EBITDA margin is 4.55%. See more stats in PROFARMA ON NM financial statements.
Like other stocks, PFRM3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROFARMA ON NM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROFARMA ON NM technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROFARMA ON NM stock shows the buy signal. See more of PROFARMA ON NM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.